These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 33016658

  • 21. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R, Reid JR, Belasco JB, Shellikeri S, Calle-Toro JS, Cahill AM, Srinivasan A.
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW, Hammill AM, Mobberley-Schuman P, Nelson SC, Blatt J, Bender JLG, McCuaig CC, Synakiewicz A, Frieden IJ, Adams DM.
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [Abstract] [Full Text] [Related]

  • 23. Intraorbital lymphatic-venous malformation in an adult patient: is sirolimus the key?
    Ruiz Velasco Santacruz A, Nieva Pascual I, Cifuentes Canorea P, Díaz Ramírez S, Pascual González M.
    Orbit; 2024 Aug; 43(4):535-538. PubMed ID: 37262366
    [Abstract] [Full Text] [Related]

  • 24. Menstrual disorders associated with sirolimus treatment.
    Triana P, López-Gutierrez JC.
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28867. PubMed ID: 33369022
    [Abstract] [Full Text] [Related]

  • 25. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
    Dvorakova V, Rea D, O'Regan GM, Irvine AD.
    Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
    [Abstract] [Full Text] [Related]

  • 26. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
    Wiegand S, Wichmann G, Dietz A.
    Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
    [Abstract] [Full Text] [Related]

  • 27. A prospective multicenter study of sirolimus for complicated vascular anomalies.
    Ji Y, Chen S, Yang K, Zhou J, Zhang X, Jiang X, Xu X, Lu G, Qiu L, Kong F, Zhang Y.
    J Vasc Surg; 2021 Nov; 74(5):1673-1681.e3. PubMed ID: 34082006
    [Abstract] [Full Text] [Related]

  • 28. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
    García-Montero P, Del Boz J, Baselga-Torres E, Azaña-Defez JM, Alcaraz-Vera M, Tercedor-Sánchez J, Noguera-Morel L, Vera-Casaño Á.
    J Am Acad Dermatol; 2019 Feb; 80(2):508-515. PubMed ID: 30296533
    [Abstract] [Full Text] [Related]

  • 29. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.
    Yu L, Xu Z, Wei L, Zhang B, Qiu L, Ma L, Li L.
    Paediatr Drugs; 2024 May; 26(3):309-317. PubMed ID: 38280106
    [Abstract] [Full Text] [Related]

  • 30. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H, Karastaneva A, Schwinger W, Benesch M, Sovinz P, Seidel M, Sperl D, Lanz S, Haxhija E, Reiterer F, Sorantin E, Urban CE.
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [Abstract] [Full Text] [Related]

  • 31. The Impact of Adjuvant Sirolimus Therapy in the Surgical Management of Scrotal Slow-Flow Vascular Malformations.
    Szhafir I, Teplisky D, Lambert G, Affranchino N, Weller S, Imizcoz FL, Corbetta JP, Sierre S.
    Urology; 2021 Jan; 147():270-274. PubMed ID: 32920033
    [Abstract] [Full Text] [Related]

  • 32. Differences in Efficacy and Safety of Sirolimus and Sildenafil in Pediatric Lymphatic Malformations.
    Wang J, Zhang X, Sun N, Liu Q, Li Y, Peng Y, Cheng X, Zhang J, Liu Y, Feng G, Liu Z, Ji T, Li X, Liu Y, Wang S, Ni X.
    Laryngoscope; 2023 Nov; 133(11):3192-3199. PubMed ID: 36861763
    [Abstract] [Full Text] [Related]

  • 33. Microcystic Lymphatic Malformation Successfully Treated With Topical Rapamycin.
    García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E.
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557723
    [Abstract] [Full Text] [Related]

  • 34. Effects of sirolimus in the treatment of unresectable infantile hemangioma and vascular malformations in children: A single-center experience.
    Cho YJ, Kwon H, Kwon YJ, Kim SC, Kim DY, Namgoong JM.
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1488-1494. PubMed ID: 33836285
    [Abstract] [Full Text] [Related]

  • 35. Successful Treatment of Macroglossia Due to Lymphatic Malformation With Sirolimus.
    Yesil S, Bozkurt C, Tanyildiz HG, Tekgunduz SA, Candir MO, Toprak S, Sahin G.
    Ann Otol Rhinol Laryngol; 2015 Oct; 124(10):820-3. PubMed ID: 25902840
    [Abstract] [Full Text] [Related]

  • 36. Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.
    Harbers VEM, Rongen GAPJM, van der Vleuten CJM, Verhoeven BH, de Laat PCJ, van der Horst CMAM, Klein WM, Schultze Kool LJ, Loo DMWMT.
    Adv Ther; 2021 Jun; 38(6):3465-3482. PubMed ID: 34003452
    [Abstract] [Full Text] [Related]

  • 37. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
    Czechowicz JA, Long-Boyle JR, Rosbe KW, Mathes EF, Frieden IJ, Shimano KA.
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
    [Abstract] [Full Text] [Related]

  • 38. Topical rapamycin and microcystic lymphatic malformations.
    Gu Y, Sebaratnam DF.
    J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
    [No Abstract] [Full Text] [Related]

  • 39. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
    Leducq S, Caille A, Barbarot S, Bénéton N, Bessis D, Boccara O, Bursztejn AC, Chiaverini C, Dompmartin A, Droitcourt C, Gissot V, Goga D, Guibaud L, Herbreteau D, Le Touze A, Léauté-Labrèze C, Lorette G, Mallet S, Martin L, Mazereeuw-Hautier J, Phan A, Plantin P, Quéré I, Vabres P, Bourgoin H, Giraudeau B, Maruani A, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.
    Trials; 2019 Dec 17; 20(1):739. PubMed ID: 31847908
    [Abstract] [Full Text] [Related]

  • 40. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
    Kim D, Benjamin L, Wysong A, Hovsepian D, Teng J.
    Dermatol Ther; 2015 Dec 17; 28(4):218-21. PubMed ID: 25753853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.